BiotechTube
Home/Pipeline/Insulin Glargine

Insulin Glargine

Diabetes Mellitus

ApprovedActive

Key Facts

Indication
Diabetes Mellitus
Phase
Approved
Status
Active
Company
Biomm

About Biomm

Brazil’s leading biotech producing insulin and biosimilar biologics for oncology and ophthalmology.

View full company profile

Therapeutic Areas

OncologyOphthalmologyEndocrinology

Other Diabetes Mellitus Drugs

DrugCompanyPhase
Insulin Aspart BiosimilarUSV Biologics DivisionCommercial
Sirolimus-Coated Balloon (SCB) - DEDICATE RegistryConcept MedicalRegistry
Gensulin (Human Insulin)BiotonApproved
Insulin Biosimilars PortfolioGEROPHARMApproved/Commercial
Biosimilar Insulin GlargineWockhardtLaunched
Biosimilar Insulin AspartWockhardtLaunched
Human InsulinEVA PharmaApproved
Insulin Analog FormulationsRPG Life SciencesANDA Filed/Development